Rankings
▼
Calendar
SLDB Q3 2025 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena
SLDB
Solid Biosciences Inc.
$644M
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$48M
Net Income
-$46M
EPS (Diluted)
$-0.48
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$33M
Free Cash Flow
-$34M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$274M
Total Liabilities
$56M
Stockholders' Equity
$218M
Cash & Equivalents
$61M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$48M
-$35M
-36.6%
Net Income
-$46M
-$33M
-39.9%
← Q2 2025
All Quarters